Checkpoint Inhibition in Myeloma: Opportunities and ChallengesFederica Costa, Madhav V. Dhodapkar|Frontiers in Immunology|2018Cited by 62
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory propertiesFederica Costa, Nicola Giuliani|Oncotarget|2017Cited by 30
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma PatientsFederica Costa, Nicola Giuliani|Frontiers in Immunology|2021Cited by 20
Study of the immune-microenvironment in Multiple Myeloma: understanding the effects of immunomodulatory drugs and the contribution of immune checkpoints in disease progressionFederica Costa|DSpasce-unipr|2019Cited by 0